PRODUCT | ORIGIN/DESCRIPTION | GRADE* | WORKING CONCENTRATION | QTY | CATALOG CODE |
TLR9 Agonists |
ODN 1826 Biotin | Biotinylated CpG ODN - mouse specific, type B | TLR2 -/ TLR4 - | 1 - 5 µM | 2 x 50 µg | tlrl-1826b |
ODN 1826 FITC | FITC-labeled CpG ODN - mouse specific, type B | TLR2 -/ TLR4 - | 1 - 5 µM | 50 µg | tlrl-1826f |
ODN 1826 VacciGrade™ | Preclinical grade ODN 1826 | VacciGrade™ | 20 - 50 µg/mouse | 1 mg | vac-1826-1 |
ODN 2006 (ODN7409) | Stimulatory CpG ODN Type B Human specifc | TLR2 -/ TLR4 - | 1 - 5 µM | 200 µg 1 mg 5 mg | tlrl-2006 tlrl-2006-1 tlrl-2006-5 |
ODN 2006 control (ODN 2137) | Negative control for ODN 2006 | TLR2 -/ TLR4 - | 1 - 5 µM | 200 µg 1 mg 5 mg | tlrl-2006c tlrl-2006c-1 tlrl-2006c-5 |
ODN 2006 Biotin | Biotinylated CpG ODN - human specific, type B | TLR2 -/ TLR4 - | 1 - 5 µM | 2 x 50 µg | tlrl-2006b |
ODN 2006 FITC | FITC-labeled CpG ODN - human specific, type B | TLR2 -/ TLR4 - | 1 - 5 µM | 50 µg | tlrl-2006f |
ODN 2006-G5 | Stimulatory CpG ODN Type B Human specific | TLR2 -/ TLR4 - | 5 µM | 200 µg 1 mg 5 mg | tlrl-2006g5 tlrl-2006g5-1 tlrl-2006g5-5 |
ODN 2006-G5 Control | Negative control for ODN 2006-G5 | TLR2 -/ TLR4 - | 5 µM | 200 µg | tlrl-2006g5c |
ODN 2006 VacciGrade™ | Preclinical grade ODN 2006 | VacciGrade™ | 20 - 50 µg/mouse | 1 mg | vac-2006-1 |
ODN 2007 | Stimulatory CpG ODN Type B Bovine / porcine | TLR2 -/ TLR4 - | 5 µM | 200 µg 1 mg 5 mg | tlrl-2007 tlrl-2007-1 tlrl-2007-5 |
ODN 2007 control | Negative control for ODN 2007 | TLR2 -/ TLR4 - | 5 µM | 200 µg 1 mg 5 mg | tlrl-2007c tlrl-2007c-1 tlrl-2007c-5 |
ODN 2216 | Stimulatory CpG ODN Type A Human specific | TLR2 -/ TLR4 - | 1 - 5 µM | 200 µg 1 mg 5 mg | tlrl-2216 tlrl-2216-1 tlrl-2216-5 |
ODN 2216 control (ODN 2138) | Negative control for ODN 2216 | TLR2 -/ TLR4 - | 1 - 5 µM | 200 µg 1 mg 5 mg | tlrl-2243 tlrl-2243-1 tlrl-2243-5 |
ODN 2216 Biotin | Biotinylated CpG ODN - human specific, type A | TLR2 -/ TLR4 - | 1 - 5 µM | 2 x 50 µg | tlrl-2216b |
ODN 2216 FITC | FITC-labeled CpG ODN - human specific, type A | TLR2 -/ TLR4 - | 1 - 5 µM | 50 µg | tlrl-2216f |
ODN 2336 | Stimulatory CpG ODN Type A Human specific | TLR2 -/ TLR4 - | 1 - 5 µM | 200 µg 1 mg 5 mg | tlrl-2336 tlrl-2336-1 tlrl-2336-5 |
ODN 2336 control | Negative control for ODN 2336 | TLR2 -/ TLR4 - | 1 - 5 M | 200 µg 1 mg 5 mg | tlrl-2336c tlrl-2336c-1 tlrl-2336c-5 |
ODN 2395 | Stimulatory CpG ODN Type C Human / mouse | TLR2 -/ TLR4 - | 5 µM | 200 µg 1 mg 5 mg | tlrl-2395 tlrl-2395-1 tlrl-2395-5 |
ODN 2395 control | Negative control for ODN 2395 | TLR2 -/ TLR4 - | 1 - 5 µM | 200 µg 1 mg 5 mg | tlrl-2395c tlrl-2395c-1 tlrl-2395c-5 |
ODN 2395 FITC | FITC-labeled CpG ODN - human specific, type C | TLR2 -/ TLR4 - | 1 - 5 µM | 50 µg | tlrl-2395f |
ODN 2395 VacciGrade™ | Preclinical grade ODN 2395 | VacciGrade™ | 20 - 50 µg/mouse | 1 mg | vac-2395-1 |
ODN BW006 (ODN684) | Class B CpG ODN, human & mouse | TLR2 -/ TLR4 - | 1 - 50 µg/ml | 200 µg | tlrl-bw006 |
ODN BW007 | Negative control for ODN BW006 | TLR2 -/ TLR4 - | 1 - 50 µg/ml | 200 µg | tlrl-bw007 |
ODN D-SL01 | Class B CpG ODN, multispecies | TLR2 -/ TLR4 - | 1 - 5 µM | 200 µg | tlrl-dsl01 |
ODN D-SL03 | Class C CpG ODN, multispecies | TLR2 -/ TLR4 - | 1 - 5 µM | 200 µg | tlrl-dsl03 |
ODN M362 | Stimulatory CpG ODN Type C Human / mouse | TLR2 -/ TLR4 - | 1 - 5 µM | 200 µg 1 mg 5 mg | tlrl-m362 tlrl-m362-1 tlrl-m362-5 |
ODN M362 Control | Negative control for ODN M362 | TLR2 -/ TLR4 - | 5 µM | 200 µg 1 mg 5 mg | tlrl-m362c tlrl-m362c-1 tlrl-m362c-5 |